Welcome to BC PharmaCare's public survey of drugs being reviewed for coverage. This survey is for ferric carboxymaltose (Ferinject) for iron deficiency (ID) in adult patients with heart failure and New York Heart Association (NYHA) class II/III to improve exercise capacity. The diagnosis of iron deficiency must be based on laboratory tests.